U.S. Pharmaceuticals & Biotech Profitable Climbers

Corcept Therapeutics

Market Cap: US$7.5b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Zevra Therapeutics

Market Cap: US$685.1m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Krystal Biotech

Market Cap: US$9.1b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Royalty Pharma

Market Cap: US$32.1b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Abeona Therapeutics

Market Cap: US$329.4m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

Alnylam Pharmaceuticals

Market Cap: US$40.3b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Kiniksa Pharmaceuticals International

Market Cap: US$3.7b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

Neurocrine Biosciences

Market Cap: US$15.9b

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

SIGA Technologies

Market Cap: US$335.7m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Liquidia

Market Cap: US$5.5b

A biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.

Omeros

Market Cap: US$799.0m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

Organon

Market Cap: US$3.5b

Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.

ADMA Biologics

Market Cap: US$1.8b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

AbbVie

Market Cap: US$384.7b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Merck

Market Cap: US$293.2b

Operates as a healthcare company worldwide.

Ascendis Pharma

Market Cap: US$13.9b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.

Jazz Pharmaceuticals

Market Cap: US$14.8b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Xeris Biopharma Holdings

Market Cap: US$1.1b

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

BeOne Medicines

Market Cap: US$32.0b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

ANI Pharmaceuticals

Market Cap: US$1.7b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Repligen

Market Cap: US$7.0b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Vericel

Market Cap: US$1.7b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

Waters

Market Cap: US$37.7b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Gilead Sciences

Market Cap: US$166.9b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Earth Science Tech

Market Cap: US$51.6m

Together with its subsidies, focuses on health and wellness industry.

Mesa Laboratories

Market Cap: US$563.6m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

Sotera Health

Market Cap: US$4.5b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Amneal Pharmaceuticals

Market Cap: US$4.2b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally.